AusPAR: Yuflyma | Therapeutic Goods Administration (TGA)

The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR

AusPAR: Yuflyma [PDF, 1.41 MB]

AusPAR: Yuflyma [Word, 2.81 MB]

AusPAR Attachment 1: Product Information for Yuflyma (auto-injector) [PDF, 1.42 MB]

AusPAR Attachment 1: Product Information for Yuflyma (auto-injector) [Word, 2.43 MB]

AusPAR Attachment 1: Product Information for Yuflyma (pre-filled syringe) [PDF, 1.64 MB]

AusPAR Attachment 1: Product Information for Yuflyma (pre-filled syringe) [Word, 2.15 MB]

Device/Product Name

Yuflyma

Active ingredients

Adalimumab

AusPAR Date

28 October 2022

Published

9 November 2022

Submission Number

PM-2021-01170-1-3

Submission Type

New biosimilar medicine

Decision

Approved